首页|靶向DAL-1基因的shRNA表达载体的构建与鉴定

靶向DAL-1基因的shRNA表达载体的构建与鉴定

扫码查看
目的:建立DAL-1稳定抑制的非小细胞肺癌(NSCLC)细胞实验模型.方法:构建靶向DAL-1的shRNA表达载体转染NSCLC细胞株,筛选出阳性克隆,在mRNA和蛋白质水平鉴定其抑制效率,最终得到DAL-1稳定抑制的细胞株.结果:通过双酶切鉴定和测序鉴定构建的shRNA表达载体序列正确,T4表达载体在mRNA和蛋白质水平能有效抑制DAL-1的表达,抑制率分别为(87.4±2.0)%和(82.7±2.1)%.结论:成功设计并构建了靶向DAL-1的shRNA表达载体,建立了DAL-1稳定抑制的NSCLC细胞株,为进一步研究DAL-1在NSCLC细胞中的作用提供了实验模型.
Construction and identification of specific shRNA interference plasmid vector targeted to DAL-1 gene mRNA
AIM: To build the experimental NSCLC cellular model in which expression of DAL-1 is steadily inhibited. METHODS: Specific shRNA interference plasmid vectors targeted to DAL-1 mRNA was constructed. The positive clones were screened by double-enzyme digestion and DNA sequencing. The expression at levels of DAL-1 mRNA and protein was detected with Q-PCR and Western blot to screen the clones in which DAL-1 was steady inhibited. RESULTS: The sequences of the constructs were confirmed by double-enzyme digestion and DNA sequencing. The expressions of DAL-1 mRNA and DAL-1 protein of T4 group decreased significantly and the inhibition rate was(87.4 ±2.0)% and (82. 7 ±2. 1)% respectively. CONCLUSION: Specific shRNA interference plasmid vector targeted to DAL-1 gene mRNA is successfully designed and constructed. NCI-H460/T cell line with stable inhibition of DAL-1 expression is established successfully , which provides experimental models for further study of the roles of DAL-A in NSCLC cells.

carcinomanon-small cell lungRNA interferenceDAL-1

徐若冰、张雅洁、郭爱林

展开 >

南方医科大学病理学教研室,广东广州,510515

广州医学院病理学教研室,广东广州,510182

广东省人民医院医学研究中心生物芯片部,广东广州,510080

癌,非小细胞肺 RNA干扰 DAL-1

广东省科技计划广东省自然科学基金广州市科技计划

2004830601011700306861002

2009

第四军医大学学报
第四军医大学

第四军医大学学报

CSTPCDCSCD北大核心
影响因子:0.599
ISSN:1000-2790
年,卷(期):2009.30(2)
  • 1
  • 13